Mesoblast Investigational Site 10774 - University of Pittsburgh — Pittsburgh, Pennsylvania

Mesoblast Investigational Site 10774 - University of Pittsburgh is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Mesoblast Investigational Site 10774 - University of Pittsburgh has participated in 1 clinical trials.

Therapeutic areas: Chronic Heart Failure.

Sponsors: Mesoblast, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mesoblast Investigational Site 10774 - University of Pittsburgh?

Mesoblast Investigational Site 10774 - University of Pittsburgh has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mesoblast Investigational Site 10774 - University of Pittsburgh conducted?

Mesoblast Investigational Site 10774 - University of Pittsburgh has 1 clinical trials on record. Their work covers Chronic Heart Failure.

Is Mesoblast Investigational Site 10774 - University of Pittsburgh accredited by Crixeo Clinical Trials?

Mesoblast Investigational Site 10774 - University of Pittsburgh has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mesoblast Investigational Site 10774 - University of Pittsburgh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.